Current oncology (Toronto, Ont.)HumansMachine LearningBiomarkersTumorUrogenital Neoplasms
Machine Learning in Biomarker-Driven Precision Oncology: Automated Immunohistochemistry Scoring and Emerging Directions in Genitourinary Cancers.
Matthew Yap, Ioana-Maria Mihai, Gang Wang
Published: 202610.3390/curroncol33010031
Abstract
Immunohistochemistry (IHC) is essential for diagnostic, prognostic, and predictive biomarker assessment in oncology, but manual interpretation is limited by subjectivity and inter-observer variability. Machine learning (ML), a computational subset of…
Preview only. Read the full abstract at the source